Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. 1977.

Hughes J, Kosterlitz HW, Smith TW.

Br J Pharmacol. 1997 Feb;120(4 Suppl):428-36; discussion 426-7. No abstract available.

2.

A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. 1972.

Henderson G, Hughes J, Kosterlitz HW.

Br J Pharmacol. 1997 Feb;120(4 Suppl):396-8; discussion 393-5. No abstract available.

3.

Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.

Sagan S, Corbett AD, Amiche M, Delfour A, Nicolas P, Kosterlitz HW.

Br J Pharmacol. 1991 Oct;104(2):428-32.

4.

Electrically-induced release of opioid peptides from the guinea-pig myenteric plexus preparation.

Corbett AD, Gillan MG, Kosterlitz HW.

J Recept Res. 1991;11(1-4):665-73.

PMID:
1886085
5.

Effect of Tris, HEPES, and TES buffers on binding at mu-, delta-, and kappa-opioid sites in guinea pig brain.

Paterson SJ, Robson LE, Kosterlitz HW, Jin WQ.

J Pharmacol Methods. 1990 Jul;23(4):275-83.

PMID:
2164621
6.

Regional variations in binding capacities at mu-, delta- and kappa-opioid sites in membrane suspensions from rabbit brain.

Petrillo P, La Regina A, Sbacchi M, Tavani A, Robson LE, Kosterlitz HW.

Eur J Pharmacol. 1989 Jul 18;166(2):213-7.

PMID:
2551699
7.

Opioid receptors and ligands.

Kosterlitz HW, Corbett AD, Paterson SJ.

NIDA Res Monogr. 1989;95:159-66. Review. No abstract available.

PMID:
2561822
8.

Cation dependence of opioid receptor binding supports theory on membrane-mediated receptor selectivity.

Sargent DF, Bean JW, Kosterlitz HW, Schwyzer R.

Biochemistry. 1988 Jul 12;27(14):4974-7.

PMID:
2901854
9.

Tissue content of opioid peptides in the myenteric plexus-longitudinal muscle of guinea-pig small intestine.

Corbett AD, McKnight AT, Kosterlitz HW.

J Neurochem. 1988 Jul;51(1):32-7.

PMID:
3379412
10.

High-performance liquid chromatography of the neuropeptides: the endogenous opioid peptides.

McKnight AT, Corbett AD, Paterson SJ, Robson LE, Kosterlitz HW.

Monogr Endocrinol. 1988;30:66-94. Review. No abstract available.

PMID:
3068528
11.

Modulation of binding at opioid receptors by mono- and divalent cations and by cholinergic compounds.

Kosterlitz HW, Paterson SJ, Robson LE.

J Recept Res. 1988;8(1-4):363-73. Review.

PMID:
2838622
12.

Biosynthesis of morphine in the animal kingdom.

Kosterlitz HW.

Nature. 1987 Dec 17-23;330(6149):606. No abstract available.

PMID:
3683582
13.

Endogenous opioids and their receptors.

Kosterlitz HW.

Pol J Pharmacol Pharm. 1987 Sep-Oct;39(5):571-6. Review.

PMID:
2852364
14.
15.

Diprenorphine has agonist activity at opioid kappa-receptors in the myenteric plexus of the guinea-pig ileum.

Traynor JR, Corbett AD, Kosterlitz HW.

Eur J Pharmacol. 1987 May 7;137(1):85-9.

PMID:
3038579
16.

Differential postnatal development of mu-, delta- and kappa-opioid binding sites in rat brain.

Petrillo P, Tavani A, Verotta D, Robson LE, Kosterlitz HW.

Brain Res. 1987 Jan;428(1):53-8.

PMID:
3815117
18.

Control by cations of opioid binding in guinea pig brain membranes.

Paterson SJ, Robson LE, Kosterlitz HW.

Proc Natl Acad Sci U S A. 1986 Aug;83(16):6216-20.

19.

Recent developments in bioassay using selective ligands and selective in vitro preparations.

Kosterlitz HW, Corbett AD, Gillan MG, McKnight AT, Paterson SJ, Robson LE.

NIDA Res Monogr. 1986;70:223-35. No abstract available.

PMID:
3020423
20.
21.

Differential postnatal development of mu-, delta-and chi-opioid binding sites in mouse brain.

Tavani A, Robson LE, Kosterlitz HW.

Brain Res. 1985 Dec;355(2):306-9.

PMID:
3002543
22.

The opioid receptors in the hamster vas deferens are of the delta-type.

McKnight AT, Corbett AD, Marcoli M, Kosterlitz HW.

Neuropharmacology. 1985 Nov;24(11):1011-7.

PMID:
3001569
23.

Has morphine a physiological function in the animal kingdom?

Kosterlitz HW.

Nature. 1985 Oct 24-30;317(6039):671-2. No abstract available.

PMID:
2997618
24.

Kappa-binding and degradation of [3H]dynorphin A (1-8) and [3H]dynorphin A (1-9) in suspensions of guinea pig brain membranes.

Gillan MG, Robson LE, McKnight AT, Kosterlitz HW.

J Neurochem. 1985 Oct;45(4):1034-42.

PMID:
2863329
25.

The Wellcome Foundation lecture, 1982. Opioid peptides and their receptors.

Kosterlitz HW.

Proc R Soc Lond B Biol Sci. 1985 Jul 22;225(1238):27-40. Review.

PMID:
2863824
26.

10-Ketonaltrexone and 10-ketooxymorphone.

Archer S, Seyed-Mozaffari A, Ward S, Kosterlitz HW, Paterson SJ, McKnight AT, Corbett AD.

J Med Chem. 1985 Jul;28(7):974-6.

PMID:
2409281
27.

Species differences in the concentrations and distributions of opioid binding sites.

Robson LE, Gillan MG, Kosterlitz HW.

Eur J Pharmacol. 1985 May 28;112(1):65-71.

PMID:
2990966
28.

Tritiated etorphine and naloxone binding to opioid receptors in caudate nucleus in schizophrenia.

Owen F, Bourne RC, Poulter M, Crow TJ, Paterson SJ, Kosterlitz HW.

Br J Psychiatry. 1985 May;146:507-9.

PMID:
2990627
29.

The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site.

Cotton R, Kosterlitz HW, Paterson SJ, Rance MJ, Traynor JR.

Br J Pharmacol. 1985 Apr;84(4):927-32.

30.

Types of opioid receptors: relation to antinociception.

Kosterlitz HW, Paterson SJ.

Philos Trans R Soc Lond B Biol Sci. 1985 Feb 19;308(1136):291-7.

PMID:
2858883
31.

Proenkephalin- and prodynorphin- derived opioid peptides in guinea-pig heart.

Weihe E, McKnight AT, Corbett AD, Kosterlitz HW.

Neuropeptides. 1985 Feb;5(4-6):453-6.

PMID:
3839054
32.

[3H]-Dynorphin A (1-8): degradation profile and binding characteristics in brain homogenates.

Gillan MG, Robson LE, McKnight AT, Kosterlitz HW.

Neuropeptides. 1985 Feb;5(4-6):533-6.

PMID:
2860610
33.

Recent developments in the bioassay of opioids.

Kosterlitz HW, Corbett AD, Gillan MG, McKnight AT, Paterson SJ, Robson LE.

Regul Pept Suppl. 1985;4:1-7. No abstract available.

PMID:
2997847
34.

Effects of D-amino acid substitution in dynorphin A (1-9) on binding at the mu-, delta- and kappa-sites.

Paterson SJ, Kosterlitz HW, Vavrek RJ, Stewart JM.

Neuropeptides. 1984 Dec;5(1-3):177-80.

PMID:
6152319
35.

Hamster vas deferens contains delta-opioid receptors.

McKnight AT, Corbett AD, Marcoli M, Kosterlitz HW.

Neuropeptides. 1984 Dec;5(1-3):97-100.

PMID:
6099523
36.
37.

Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.

Corbett AD, Gillan MG, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE.

Br J Pharmacol. 1984 Sep;83(1):271-9.

38.

Opioid binding sites of the kappa-type in guinea-pig cerebellum.

Robson LE, Foote RW, Maurer R, Kosterlitz HW.

Neuroscience. 1984 Jun;12(2):621-7.

PMID:
6087201
39.

Radioligands for probing opioid receptors.

Paterson SJ, Corbett AD, Gillan MG, Kosterlitz HW, McKnight AT, Robson LE.

J Recept Res. 1984;4(1-6):143-54.

PMID:
6098650
40.

Metorphamide: isolation, structure, and biologic activity of an amidated opioid octapeptide from bovine brain.

Weber E, Esch FS, Böhlen P, Paterson S, Corbett AD, McKnight AT, Kosterlitz HW, Barchas JD, Evans CJ.

Proc Natl Acad Sci U S A. 1983 Dec;80(23):7362-6.

41.

Increase in potencies of opioid peptides after peptidase inhibition.

McKnight AT, Corbett AD, Kosterlitz HW.

Eur J Pharmacol. 1983 Jan 21;86(3-4):393-402.

PMID:
6299758
42.

Characterization of opioid peptides in guinea-pig heart and skin.

Weihe E, McKnight AT, Corbett AD, Hartschuh W, Reinecke M, Kosterlitz HW.

Life Sci. 1983;33 Suppl 1:711-4.

PMID:
6363857
43.

Lysine substitution increases mu-selectivity of potent di- and tri-peptide enkephalin analogs.

Vavrek RJ, Cui RL, York EJ, Stewart JM, Paterson S, Kosterlitz HW.

Life Sci. 1983;33 Suppl 1:451-4.

PMID:
6319902
44.

[3H]-dynorphin A (1-9): binding characteristics and degradation profile in brain homogenates.

Robson LE, Gillan MG, McKnight AT, Kosterlitz HW.

Life Sci. 1983;33 Suppl 1:283-6.

PMID:
6319878
45.

Interactions of some 4-anilinopiperidines and 4-phenylpiperidines with the mu, delta- and kappa-binding sites.

Jin WQ, Paterson SJ, Kosterlitz HW, Casy AF.

Life Sci. 1983;33 Suppl 1:251-3.

PMID:
6319871
46.

Classification of opioid receptors.

Paterson SJ, Robson LE, Kosterlitz HW.

Br Med Bull. 1983 Jan;39(1):31-6. Review. No abstract available.

PMID:
6301606
47.

Opioid Peptides: introduction.

Hughes J, Kosterlitz HW.

Br Med Bull. 1983 Jan;39(1):1-3. No abstract available.

PMID:
6301604
48.

The role of interaction between opiate receptors and alpha-adrenergic receptors in tolerance and dependence.

Robson LE, Mucha RF, Kosterlitz HW.

Biochem Soc Trans. 1983 Jan;11(1):64-5. No abstract available.

PMID:
6298026
49.

Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain.

Gillan MG, Kosterlitz HW.

Br J Pharmacol. 1982 Nov;77(3):461-9.

50.

Comparison of in vitro potencies in pharmacological and binding assays after inhibition of peptidases reveals that dynorphin (1-9) is a potent kappa-agonist.

McKnight AT, Corbett AD, Paterson SJ, Magnan J, Kosterlitz HW.

Life Sci. 1982 Oct 18-25;31(16-17):1725-8. No abstract available.

PMID:
6130431

Supplemental Content

Loading ...
Support Center